Episode Links and References
Ohio State University’s Center for Psychedelic Drug Research and Education (CPDRE)
Episode Links and References
Ohio State University’s Center for Psychedelic Drug Research and Education (CPDRE)
My guest today is Dr Chris Letheby, a philosopher working on issues related to psychedelic drugs, who is currently a lecturer in philosophy at the University of Western Australia and a postdoctoral researcher at the University of Adelaide. Chris is also the author of the book Philosophy of Psychedelics, which was published in 2021 by Oxford University Press.
In this conversation we touch on the account given in Chris’ book of the therapeutic benefits of psychedelics, and then go deep into Chris’ account of the phenomenology of psychedelics. This conversation was a lot of fun, and I hope you enjoy it as much as I did.
I also want to explicitly recommend Chris’ book. I think it does an excellent job of drawing together a whole range of different types of research to provide a clear and sophisticated framework for understanding how psychedelics have their therapeutic and transformational effects, and the consequent philosophical implications.
Show Notes
2:45 – The question that Philosophy of Psychedelics is organised around: “Is psychedelic therapy simply foisting a comforting delusion on the sick and dying”?
6:15 – Chris’ theory about what is happening in the psychedelic experience, the hierarchical self-binding account.
16:20 – How the hierarchical self-binding theory accounts for the phenomenology of the mystical experience.
33:10 – How the hierarchical self-binding theory accounts for other remarkable aspects of the psychedelic/mystical experience – the sense that everything is conscious and the sense that the experience is True.
43:50 – How the hierarchical self-binding theory accounts for other remarkable aspects of the psychedelic/mystical experience – the sense of sacredness and the fundamentalness of love.
50:20 – What’s coming up for Chris and what he hopes to see in the next decade of psychedelic research.
Episode Links and References
Chris’ book – Philosophy of Psychedelics
Philip Gerrans – a frequent collaborator of Chris’.
Anil Seth – neuroscientist advocating the view that what we perceive as reality is a “controlled hallucination”.
Thomas Metzinger – a philosopher of mind exploring self-hood and subjective experience.
Today I speak with Dr. Vince Polito (@vincepsy), Research Fellow in the Department of Cognitive Science at Macquarie University. Vince works on developing better measures of self representation and investigating how this capacity is altered in different contexts, clinical conditions and states of consciousness.
Vince and I discuss microdosing, which refers to regularly taking very small doses of psychedelic substances. Earlier this year, Vince published one of the most rigorous studies conducted on microdosing to date.
This is an interesting topic because of its link to the promising therapeutic psychedelic studies currently being undertaken, the positive reports of microdosing in the media, and the lack of empirical research into the practice. We discuss these preliminary investigations and the outlook for this field.
Show Notes
1:10 – On Vince’s research background
7:20 – How Vince came to be interested in microdosing
13:30 – On the methodology and findings of Vince’s microsdosing paper.
22:00 – On the plausibility and continuity of microdosing effects with higher dose psychedelics
25:30 – On how to square the reported benefits of microdosing with the fact that the therapeutic effect of psychedelics are related to the intensity of experience (eg. Griffiths et al., 2017).
31:50 – What do altered states of consciousness, more broadly, have to offer cognitive science?
36:50 – Advice to students interested in similar areas.
39:10 – On meditation as an altered state of consciousness.
43:00 – What’s coming up for Vince in terms of research.
.
Episode References
Robin Carhart-Harris and Karl Friston’s recent (2019) paper proposing a relaxing of prior beliefs within a hierarchical predictive coding framework as a model of how psychedelics have their effects. “REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics“.
Today we speak with Dr. Stephen Bright, a clinically-trained psychologist, ethnopharmacologist and Senior Lecturer of Addiction at Edith Cowan University.
Stephen has over 15 years experience in Alcohol and Other Drug (AOD) research, harm reduction and mental health. He is a member of the AOD Media Watch Reference Group, an organisation that highlights poor examples of journalism regarding AOD-related issues. He is also a founding member and vice-president of PRISM, a not-for-profit organisation supporting research into harm reduction, evidence-based drug policy and the medical application of psychoactive drugs including psychedelics.
And finally, please accept my apologies for the recording quality of this episode. My lack of experience is solely to blame. I hope it doesn’t take away from what was an interesting conversation.
Show Notes
1:30 – On animal drug use.
4:20 – On human drug use across time and space and the distinctly different view dominant today, which Stephen describes as ‘psychophobia’.
8:40 – On harnessing the therapeutic potential of psychedelics without the psychedelic experience.
12:20 – On how MDMA and psylocibin work.
21:30 – On the experience of being a clinician administering MDMA-assisted psychotherapy.
28:00 – On the potential of and challenges facing psychedelics within psychology and psychiatry.
33:45 – On other important and contemporary areas of human-drug relations.
40:30 – On the transfer of current alcohol use culture to drug use.
43:40 – On media portrayals of drugs.
Episode References
Stephen’s homepage at Edith Cowan University, with links to his Twitter profile and research.
Default mode network and two papers examining how it is impacted by psychedelics (1 and 2).
MAPS MDMA Therapist Training Program
Today we speak with Dr. Nigel Strauss, a psychiatrist with over 40 years experience and Adjunct Professor at Deakin University.
Nigel’s career has focused on medico-legal psychiatry, in particular Post-Traumatic Stress Disorder (PTSD). He is Director of Occupational Psychiatry Pty. Ltd. which integrates psychiatry into the workplace.
Prompted by the extraordinary results of MDMA-assisted psychotherapy in the treatment of PTSD (which was recently granted breakthrough therapy designation by the US FDA), Nigel became interested in the therapeutic potential of MDMA and other psychedelics, a stigmatised but therapeutically promising class of drugs.
Nigel now advocates for psychedelic-research in Australia and has published a number of papers on the subject.
Episode References
Millswyn Clinic – Nigel’s workplace
Multidisciplinary Association for Psychedelic Study
MDMA-assisted psychotherapy granted breakthrough therapy designation
Psylocibin-assisted psychotherapy granted breakthrough therapy designation
Nigel’s paper advocating for psychedelic research in Australia
Nigel’s paper on psilocybin-assisted therapy for terminally ill patients with anxiety and depression